mirtazapine has been researched along with Bulimia in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Bulimia: Eating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as ox hunger.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schüle, C | 1 |
| Sighart, C | 1 |
| Hennig, J | 1 |
| Laakmann, G | 1 |
1 trial available for mirtazapine and Bulimia
| Article | Year |
|---|---|
Mirtazapine inhibits salivary cortisol concentrations in anorexia nervosa.
Topics: Adult; Anorexia Nervosa; Antidepressive Agents; Body Mass Index; Bulimia; Data Interpretation, Stati | 2006 |